Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin

Am J Respir Crit Care Med. 2024 Jun 1;209(11):1394-1396. doi: 10.1164/rccm.202309-1699LE.

Tommaso Bucci^{1

2}, Dennis Wat^{1

3}, Dilip Nazareth^{1

3}, Sarah Sibley³, Dan Wootton^{4

5}, Gregory Y H Lip^{1

6}, Freddy Frost^{1

3}

¹ Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
² Department of General and Specialized Surgery, Sapienza University of Rome, Rome, Italy.
³ Knowsley Community Respiratory Service and.
⁴ Respiratory Department, Liverpool Heart & Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom.
⁵ Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom; and.
⁶ Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

No abstract available

Publication types